Back to search

Germany· DE-A57-c799f76d8edcd050

Sulpirid Neuraxpharm

A sulpiride product containing sulpiride, registered in Germany by Neuraxpharm Arzneimittel Gmbh. The same ATC class is registered in 12 of our 19 countries.

ATC N05AL01

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedSulpirid NeuraxpharmATCN05AL01REGISTER NO.DE-A57-c799f76d8edcd0…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Sulpiride is registered in 12 of 19 countries.

Countries holding a registration under ATC N05AL01 (sulpiride), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 7 of them publish a price we can compare per daily dose

Sulpiride · ATC N05AL01

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sulpiride costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $1.00 in France to $3.83 in Switzerland — a ×3.8 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Sulpiride · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.83
  • FR France$1.00
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Sulpiride
Manufacturer
Neuraxpharm Arzneimittel Gmbh
Country
Germany (DE)
ATC code
N05AL01
ATC class
Sulpiride
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

23 interactions on record for sulpiride.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sulpiride · interactions on record

23 records

23 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Sulpiride in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulpiride products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Dogmatil, Sulpirid Grindeks
  • Belgium · Dogmatil, Sulpiride Eg
  • Cyprus · Devodil, Sulpiren
  • Czechia · Dogmatil, Prosulpin
  • Estonia · Betamaks
  • Spain · Dogmatil, Dogmatil Fuerte
  • Finland · Suprium
  • France · Dogmatil, Dogmatil Sans Sucre, Édulcorée Au Cyclamate De Sodium
  • United Kingdom (Northern Ireland) · Sulpiride, Sulpiride Activase Pharmaceuticals
  • Greece · Dogmatyl
  • Croatia · Eglonyl, Eglonyl Forte
  • Hungary · Depral
  • Ireland · Dolmatil
  • Italy · Dobren
  • Lithuania · Eglonyl
  • Luxembourg · Dogmatil, Sulpiride Eg
  • Latvia · Betamaks
  • Malta · Devodil, Sulpiride Grindeks
  • Netherlands · Dogmatil
  • Poland · Sulpiryd Hasco, Sulpiryd Teva
  • Portugal · Dogmatil, Dogmatil Forte
  • Romania · Eglonyl
  • Slovenia · Eglonyl
  • Slovakia · Betamaks, Sulpirid Belupo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ac5bffac-b10f-44a3-a10f-53016653af0e
GET /v1/drugs/ac5bffac-b10f-44a3-a10f-53016653af0e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Sulpiride",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about sulpiride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.